Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium

Urology

Volumn 53, Issue 1, 1999, Pages 92-97

  Pycha, Armin ^a   Mian, Christine ^a   Hofbauer, Johann ^a   Brössner, Clemens ^a   Haitel, Andrea ^a   Wiener, Helene ^a   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DNA CONTENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 0032950750     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00461-0     Document Type: Article

References (24)

1. Hastie K.J., Hamdy F.C., Collins M.C., et al. Upper tract tumours following cystectomy for bladder cancer. Is routine intravenous urography worthwhile? Br J Urol. 67:1991;29-31.
2. Kakizoe T., Tobisu K., Tanaka Y., et al. Development of multiple transitional cell cancer in the urinary tract. Jpn J Clin Oncol. 21:1991;110-114.
3. Schwartz C.B., Bekirov H., Melman A. Urothelial tumors of upper urinary tract following treatment of primary bladder transitional cell carcinoma. Urology. 40:1992;509-511.
4. Herr H.W., Cookson M.S., Soloway M.S. Upper tract tumors in patients with primary bladder cancer followed for 15 years. J Urol. 156:1996;1286-1287.
5. Olumi A.F., Tsai Y.C., Nichols P.W., et al. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res. 50:1990;7081-7083.
6. Meloni A.M., Peier A.M., Haddad F.S., et al. A new approach in the diagnosis and follow up of bladder cancer. Cancer Genet Cytogenet. 71:1993;105-118.
7. Spruck C.H. III, Ohneseit P.F., Gonzales-Zulueta M., et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. 54:1994;784-788.
8. Poddighe P.J., Bringuier P.P., Vallinga M., et al. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. J Pathol. 179:1996;169-176.
9. Sauter G., Gasser T.C., Moch H., et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res. 25:(suppl 1):1997;S37-S43.
10. Waldman F.M., Caroll P.R., Kerschmann R., et al. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res. 51:1991;3807-3813.
11. Wheeless L.L., Reeder J.E., Han R., et al. Bladder irrigation specimens assayed by fluorescence in situ hybridisation to interphase nuclei. Cytometry. 17:1994;319-326.
12. Sandberg A.A., Berger C.S. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol. 151:1994;545-560.
13. Sauter G., Deng G., Moch H., et al. Physical deletion of the p53 gene in bladder cancer. Am J Pathol. 144:1994;756-766.
14. Mellon K., Wilkinson S., Vickers J. Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder. Br J Urol. 73:1994;522-525.
15. Moch H., Sauter G., Gudat F., et al. Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosome 7 and 17) in formalin fixed bladder tumors. Verh Dtsch Ges Pathol. 77:1993;226-230.
16. Mellon K., Neal D.E., Robinson M.C., et al. Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67. Br J Urol. 66:1990;281-285.
17. Tetû B., Allard P., Fradet Y., et al. Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary superficial bladder cancer. Hum Pathol. 27:1996;922-926.
18. Kakizoe T., Fujita J., Murase T., et al. Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. J Urol. 124:1980;17-19.
19. Sobin L.H., Wittekind C.H. UICC TNM Classification of Malignant Tumours. 5th ed. 1997;Wiley-Liss, New York.
20. Pycha A., Mian C., Haitel A., et al. Fluorescence in situ hybridization identifies more aggressive types of primarily non invasive (pTa) bladder cancer. J Urol. 157:1997;2116-2119.
21. Van der Poel H.G., Witjes J.A., van Stratum P., et al. Quanticyt karyometric analysis of bladder washings for patients with superficial bladder cancer . Urology. 48:1996;357-364.
22. Sidransky D., Von Eschenbach A., Tsai Y.C., et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science. 252:1991;706-709.
23. Dalbagni G., Presti J.C., Reuter V.E., et al. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol. 2:1993;4-13.
24. Sarkis A.S., Dalbagni G., Cordon-Cardo C., et al. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol. 152:1994;388-392.